1 – 22 of 22
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
(
- Contribution to journal › Article
- 2015
-
Mark
Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels.
(
- Contribution to journal › Article
- 2014
-
Mark
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
(
- Contribution to journal › Article
-
Mark
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.
(
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article
- 2013
-
Mark
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy.
(
- Contribution to journal › Article
-
Mark
Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.
(
- Contribution to journal › Article
- 2010
-
Mark
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
(
- Contribution to journal › Article
- 2009
-
Mark
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity.
(
- Contribution to journal › Article
- 2004
-
Mark
Five-Year Outcome of Cholinergic Treatment of Alzheimer's Disease: Early Response Predicts Prolonged Time until Nursing Home Placement, but Does Not Alter Life Expectancy.
(
- Contribution to journal › Article
- 1998
-
Mark
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease
(
- Contribution to journal › Article
- 1997
-
Mark
The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
(
- Contribution to journal › Article
-
Mark
Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia
(
- Contribution to journal › Article
- 1996
-
Mark
Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia
(
- Contribution to journal › Article
- 1995
-
Mark
Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease
(
- Contribution to journal › Article
- 1994
-
Mark
Neuropsychological tests as discriminators between dementia of Alzheimer type and frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Tacrine treatment modifies cerebrospinal fluid neuropeptide levels in Alzheimer's disease
(
- Contribution to journal › Article
- 1993
-
Mark
Cortical blood flow during head-up postural change in subjects with orthostatic hypotension
1993) In Clinical autonomic research : official journal of the Clinical Autonomic Research Society 3(5). p.311-318(
- Contribution to journal › Article
-
Mark
Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration
(
- Contribution to journal › Article
-
Mark
Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG
(
- Contribution to journal › Article
- 1992
-
Mark
Redistribution of blood flow in the cerebral cortex of normal subjects during head-up postural change
1992) In Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2(2). p.119-124(
- Contribution to journal › Article
- 1990
-
Mark
Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration
(
- Contribution to journal › Article